Physician profile
Addie Alkhas
NPI 1649242736
$4,787.40
in general payments reported to CMS, 2019-2025
8 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,451 · 2020: $3,000 · 2024: $39.99 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,388.85 | 2019-2020 | |
| Baxter Healthcare | $107.14 | 2025 | Floseal |
| On Target Laboratories, INC | $97.42 | 2025 | Cytalux |
| Astrazeneca Pharmaceuticals LP | $61.76 | 2019 | |
| Glaxosmithkline, LLC. | $39.99 | 2024 | |
| Conmed Corporation | $35.71 | 2025 | Airseal |
| Hologic Sales and Service, LLC | $28.77 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Sumitomo Pharma America, INC. | $27.76 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Addie Alkhas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.